Table 3.
Variable | p-Value Anova (Effect Size f2%) | p-Value (SBPRE vs. PLAPRE) | SBPRE | SBPOST | p-Value (SBPRE vs. SBPOST) | PLAPRE | PLAPOST | p-Value (PLAPRE vs. PLAPOST) | p-Value (SBPOST vs. PLAPOST) | |
---|---|---|---|---|---|---|---|---|---|---|
Peak power (W) | WT1 | 0.6021 (0.5%) | 1.0000 | 834 ± 316 (714–954) |
903 ± 330 (777–1028) |
0.1826 | 802 ± 310 (657–947) |
837 ± 288 (702–972) |
1.0000 | 1.0000 |
WT2 | 1.0000 | 791 ± 173 (678–903) |
886 ± 172 (769–1003) |
0.0032 | 751 ± 147 (631–870) |
801 ± 142 (676–927) |
1.0000 | 1.0000 | ||
Average power (W) | WT1 | 0.0862 (2.6%) | 1.0000 | 548 ± 102 (482–613) |
553 ± 108 (487–618) |
1.0000 | 526 ± 80 (457–595) |
530 ± 90 (464–596) |
1.0000 | 1.0000 |
WT2 | 1.0000 | 517 ± 296 (452–582) |
543 ± 309 (479–607) |
0.0097 | 507 ± 255 (440–574) |
511 ± 268 (444–579) |
1.0000 | 1.0000 | ||
Minimum power (W) | WT1 | 0.3575 (1.1%) | 1.0000 | 336 ± 171 (297–375) |
327 ± 168 (286–368) |
1.0000 | 319 ± 143 (282–357) |
307 ± 144 (265–349) |
1.0000 | 1.0000 |
WT2 | 1.0000 | 297 ± 97 (260–334) |
298 ± 110 (256–340) |
1.0000 | 301 ± 87 (261–342) |
290 ± 85 (250–330) |
1.0000 | 1.0000 |
Values are mean ± SD (and 95% confidence intervals). Abbreviations: SBpre—before sodium bicarbonate supplementation, SBpost—after sodium bicarbonate supplementation, PLApre—before placebo treatment, PLApost—after placebo treatment, WT1—the Wingate test before the dummy throw test, WT2—the Wingate test after the dummy throw test.